FOR The Second Time, Archimedes Makes the Inc. 5000 List of Fastest-Growing Private Companies

BRENTWOOD, TN August 13, 2024 – Archimedes, a recognized leader in specialty drug management solutions, has been named to the 2024 Inc. 5000 list of fastest-growing private companies in America for the second consecutive year – ranking in the top 1000 overall and in the top 100 in the Health Services industry.  The prestigious list provides a data-driven look at the most successful companies within the economy’s most dynamic segment—independent, entrepreneurial businesses. Facebook, Chobani, Under Armour, Microsoft, Patagonia, and many other household-name brands gained their first national exposure as honorees on the Inc. 5000.

“Making the Inc. 5000 list for a second year is a testament to the growing number of employers who see through the pitfalls of traditional PBM models and are looking for a more effective way to manage specialty medications.” said Dr. Brenda Motheral PhD, CEO and Co-Founder of Archimedes. “Our demonstrated results in reducing specialty drug spend has been the key ingredient to our success and driver of our extraordinary growth. We expect the employee lawsuits at J&J and now Wells Fargo to further increase employer attention on working with a PBM that will be held accountable for true cost management.”

Archimedes’ specialty drug management programs are delivering reductions in specialty spend ranging from 30-50% in the first year following the program and are providing sustained lower spend over multiple years. At the patient level, Archimedes has delivered savings as much as $1M per patient annually while improving clinical outcomes.

For complete results of the Inc. 5000, including company profiles and an interactive database that can be sorted by industry, location, and other criteria, click here.

About Archimedes

Archimedes is the industry leader in specialty drug management solutions. Founded with the goal of transforming the PBM industry to provide the necessary ingredients for the sustainability of the prescription drug benefit – alignment, value and transparency – Archimedes achieves superior results for clients by eliminating tightly held PBM conflicts of interest including drug spread, rebate retention and pharmacy ownership and delivering the most rigorous clinical management at the lowest net cost.

For media inquiries contact info@archimedesrx.com.